Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics

NCT00997477 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Foradil Combi (Formoterol-budesonide)

Sponsor

Novartis Pharmaceuticals